載入...
Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances
OBJECTIVES: Alteplase is commonly recommended for acute ischaemic stroke within 4.5 hours after stroke onset. The Third European Cooperative Acute Stroke Study (ECASS III) is the only trial reporting statistically significant efficacy for clinical outcomes for alteplase use 3–4.5 hours after stroke...
Na minha lista:
| 發表在: | BMJ Evid Based Med |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7548536/ https://ncbi.nlm.nih.gov/pubmed/32430395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjebm-2020-111386 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|